An α7 Nicotinic Acetylcholine Receptor-Selective Agonist Reduces Weight Gain and Metabolic Changes in a Mouse Model of Diabetes
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A specific α7 agonist (TC-7020 106 ) and the β2 agonist sazetidine-A 107 both reduce weight gain and/or food intake in mouse models.”
From Nicotinic Acetylcholine Receptor Signaling in the Hypothalamus: Mechanisms Related to Nicotine’s Effects on Food Intake (2020) · cites this paper as [106]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
Borovikova, L. V., Ivanova, S., Zhang, M., Yang, H., Botchkina, G. I., Watkins, L. R., Wang, H., Abumrad, N., Eaton, J. W., & Tracey, K. J. (2000) · Nature · doi:10.1038/35013070 · Cited by 4,211
Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation
Wang, H., Yu, M., Ochani, M., Amella, C. A., Tanovic, M., Susarla, S., Li, J. H., Wang, H., Yang, H., Ulloa, L., et al. (2003) · Nature · doi:10.1038/nature01339 · Cited by 3,228
Protection from obesity-induced insulin resistance in mice lacking TNF-α function
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234 · cited 2×
“…plasma concentrations of inflammatory mediators such as TNF- are increased in the insulin-resistant diabetic state, and that the reduction of the levels of TNF- in diabetic mice correlates with increased insulin sensitivity and decreased plasma insulin and blood glucose levels (Uysal et al., 1997).”
Inflammation: the link between insulin resistance, obesity and diabetes
Dandona, P. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.10.013 · Cited by 2,170 · cited 1×
“TNF- has been shown not only to evoke the production of other inflammatory cytokines but also to increase the activities of signaling pathways that are believed to lead to insulin resistance (Dandona et al., 2004).”
de Jonge, W. J., van der Zanden, E. P., The, F. O., Bijlsma, M. F., van Westerloo, D. J., Bennink, R. J., Berthoud, H.-R., Uematsu, S., Akira, S., van den Wijngaard, R. M., et al. (2005) · Nature Immunology · doi:10.1038/ni1229 · Cited by 1,074
Inflammatory mechanisms in the regulation of insulin resistance
Tilg, H., & Moschen, A. R. (2008) · Molecular Medicine · doi:10.2119/2007-00119.tilg · Cited by 779
Nicotinic receptor‐mediated effects on appetite and food intake
Jo, Y., Talmage, D. A., & Role, L. W. (2002) · Journal of Neurobiology · doi:10.1002/neu.10147 · Cited by 323
Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation
Borovikova, L. V., Ivanova, S., Nardi, D., Zhang, M., Yang, H., Ombrellino, M., & Tracey, K. J. (2000) · Autonomic Neuroscience · doi:10.1016/s1566-0702(00)00233-2 · Cited by 322
Comparative pharmacology of rat and human α7 nAChR conducted with net charge analysis
Papke, R. L., & Porter Papke, J. K. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704833 · Cited by 249
Research works printed but not linked: 24
- Ahima, 2006, Adipokines that link obesity and diabetes to the hypothalamus, Prog Brain Res, 153, 155, 10.1016/S0079-6123(06)53009-2 · DOI
- Bulló, 2003, Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression, Obes Res, 11, 525, 10.1038/oby.2003.74 · DOI · Paper page
- Cheng, 1973, Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction, Biochem Pharmacol, 22, 3099, 10.1016/0006-2952(73)90196-2 · DOI · Paper page
- Davies, 1999, Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling alpha 7-type neuronal nicotinic acetylcholine receptors, Neuropharmacology, 38, 679, 10.1016/S0028-3908(98)00221-4 · DOI · Paper page
- de Jonge, 2007, The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation, Br J Pharmacol, 151, 915, 10.1038/sj.bjp.0707264 · DOI · Paper page
- Fornari, 2007, Nicotine withdrawal increases body weight, neuropeptide Y and Agouti-related protein expression in the hypothalamus and decreases uncoupling protein-3 expression in the brown adipose tissue in high-fat fed mice, Neurosci Lett, 411, 72, 10.1016/j.neulet.2006.10.014 · DOI · Paper page
- Gallowitsch-Puerta, 2005, Immunologic role of the cholinergic anti-inflammatory pathway and the nicotinic acetylcholine alpha 7 receptor, Ann N Y Acad Sci, 1062, 209, 10.1196/annals.1358.024 · DOI · Paper page
- Harris, 2001, Metabolic responses to leptin in obese db/db mice are strain dependent, Am J Physiol Regul Integr Comp Physiol, 281, R115, 10.1152/ajpregu.2001.281.1.R115 · DOI
- Hotamisligil, 1993, Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance, Science, 259, 87, 10.1126/science.7678183 · DOI · Paper page
- Jo, 2005, Cholinergic modulation of appetite-related synapses in mouse lateral hypothalamic slice, J Neurosci, 25, 11133, 10.1523/JNEUROSCI.3638-05.2005 · DOI · Paper page
- Li, 2003, Effect of nicotine on the expression of leptin and forebrain leptin receptors in the rat, Brain Res, 991, 222, 10.1016/j.brainres.2003.08.024 · DOI
- Lippiello, 1986, The binding of L-[3H]nicotine to a single class of high affinity sites in rat brain membranes, Mol Pharmacol, 29, 448, 10.1016/S0026-895X(25)10280-0 · DOI · Paper page
- Liu, 2004, The expression and functional role of nicotinic acetylcholine receptors in rat adipocytes, J Pharmacol Exp Ther, 310, 52, 10.1124/jpet.103.065037 · DOI
- Maasen, 2008, Mitochondria, body fat and type 2 diabetes: what is the connection?, Minerva Med, 99, 241
- Mabley, 2002, Nicotine reduces the incidence of type I diabetes in mice, J Pharmacol Exp Ther, 300, 876, 10.1124/jpet.300.3.876 · DOI
- Marrero, 2009, Convergence of alpha 7 nicotinic acetylcholine receptor-activated pathways for anti-apoptosis and anti-inflammation: central role for JAK2 activation of STAT3 and NF-kappaB, Brain Res, 1256, 1, 10.1016/j.brainres.2008.11.053 · DOI
- Miao, 2003, Vagal modulation of spinal nicotine-induced inhibition of the inflammatory response mediated by descending antinociceptive controls, Neuropharmacology, 45, 605, 10.1016/S0028-3908(03)00224-7 · DOI
- Ruan, 2003, Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha, Cytokine Growth Factor Rev, 14, 447, 10.1016/S1359-6101(03)00052-2 · DOI · Paper page
- Sharma, 2003, Diabetic kidney disease in the db/db mouse, Am J Physiol Renal Physiol, 284, F1138, 10.1152/ajprenal.00315.2002 · DOI · Paper page
- Sykiotis, 2001, Serine phosphorylation of insulin receptor substrate-1: a novel target for the reversal of insulin resistance, Mol Endocrinol, 15, 1864
- Turek, 1995, A sensitive technique for the detection of the alpha 7 neuronal nicotinic acetylcholine receptor antagonist, methyllycaconitine, in rat plasma and brain, J Neurosci Methods, 61, 113, 10.1016/0165-0270(95)00032-P · DOI
- Wild, 2004, Global prevalence of diabetes: estimates for the year 2000 and projections for 2030, Diabetes Care, 27, 1047, 10.2337/diacare.27.5.1047 · DOI · Paper page
- Williams, 2003, Weight loss-induced plasticity of glucose transport and phosphorylation in the insulin resistance of obesity and type 2 diabetes, Diabetes, 52, 1619, 10.2337/diabetes.52.7.1619 · DOI · Paper page
- Zeyda, 2007, Adipose tissue macrophages, Immunol Lett, 112, 61, 10.1016/j.imlet.2007.07.003 · DOI · Paper page
Cited by
The vagus nerve and the inflammatory reflex – linking immunity and metabolism
Pavlov, V. A., & Tracey, K. J. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.189 · Cited by 1,040
Hosomi, K., Saito, M., Park, J., Murakami, H., Shibata, N., Ando, M., Nagatake, T., Konishi, K., Ohno, H., Tanisawa, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32015-7 · Cited by 451
Pavlov, V. A., & Tracey, K. J. (2015) · Immunologic Research · doi:10.1007/s12026-015-8718-1 · Cited by 254
“Exploring vagus nerve-based cholinergic neurocircuitry in metabolic and inflammatory regulation in obesity is an emerging approach that has been experimentally tested by using cholinergic modalities, including the acetylcholinesterase inhibitor galantamine [164] and a7nAChR agonists [165, 166].”
MethodKeever, K. R., Yakubenko, V. P., & Hoover, D. B. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106758 · Cited by 82
Calarco, C. A., & Picciotto, M. R. (2020) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntz010 · Cited by 40
Metadata
- Authors
- Marrero, M. B., Lucas, R., Salet, C., Hauser, T. A., Mazurov, A., Lippiello, P. M., & Bencherif, M.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 332
- Issue
- 1
- Pages
- 173-180
- ISSN
- 0022-3565
- Cited by
- 97
- References
- 9
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An α7 Nicotinic Acetylcholine Receptor-Selective Agonist Reduces Weight Gain and Metabolic Changes in a Mouse Model of Diabetes. https://app.cochat.ai/papers/10.1124/jpet.109.154633
- The paper
- Marrero, M. B., Lucas, R., Salet, C., Hauser, T. A., Mazurov, A., Lippiello, P. M., & Bencherif, M. (2010). An α7 Nicotinic Acetylcholine Receptor-Selective Agonist Reduces Weight Gain and Metabolic Changes in a Mouse Model of Diabetes. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1124/jpet.109.154633
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.